4/26/2012

The NIH awarded Thermalin Diabetes a $4.5 million grant to fund development and animal trials of next-generation insulin analogs. Unlike the natural hormone, Thermalin's analogs can be modified to tolerate heat or act faster or slower than insulin to match a patient's needs.

Full Story:
MedCityNews.com

Related Summaries